Xin Liu
Chief Executive Officer bij National Innovation Center for High Performance Medical
Profiel
Xin Liu is an Independent Non-Executive Director at Insight Lifetech Co., Ltd., a Professor at The Shenzhen Institutes of Advanced Technology, and the General Manager at National Innovation Center for High Performance Medical.
Liu received a graduate degree from Wuhan University in 1993 and an undergraduate degree from the same university in 1988.
Actieve functies van Xin Liu
| Bedrijven | Functie | Begin |
|---|---|---|
Insight Lifetech Co., Ltd.
 Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Director/Board Member | 30-06-2021 |
| The Shenzhen Institutes of Advanced Technology | Corporate Officer/Principal | 01-02-2010 |
| National Innovation Center for High Performance Medical | Chief Executive Officer | 01-02-2021 |
Opleiding van Xin Liu
| Wuhan University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Insight Lifetech Co., Ltd.
Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Health Technology |
| National Innovation Center for High Performance Medical |
